Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):110–6. https://doi.org/10.2174/1570161117666190405165151.

Article  CAS  PubMed  Google Scholar 

Pollack CV, Amin A, Wang T, Deitelzweig S, Cohen M, Slattery D, Fanikos J, DiLascia C, Tuder R, Kaatz S. Contemporary NSTEMI management: the role of the hospitalist. Hosp Pract. 2020;48(1):1–11. https://doi.org/10.1080/21548331.2020.1701329.

Article  Google Scholar 

Zhang Y, Wang R, Fu X, Song H. Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease. Diabetol Metab Syndr. 2022;14(1):191. https://doi.org/10.1186/s13098-022-00967-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hawranek M, Gąsior M, Nożyński J, Poloński L. Causes of mortality in patients with myocardial infarction in the reperfusion. Folia Cardiol. 2004;11(4):239–45.

Google Scholar 

Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. https://doi.org/10.1186/s12933-018-0703-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, Kim JH, Park JS. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–73. https://doi.org/10.2337/dc18-1920.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Liu C, Xu Y, Wang Y, Dai F, Hu H, Jiang T, Lu Y, Zhang Q. The management correlation between metabolic index, cardiovascular health, and diabetes combined with cardiovascular disease. Front Endocrinol. 2023;27(13):1036146. https://doi.org/10.3389/fendo.2022.1036146.

Article  Google Scholar 

Gazzaruso C, Solerte SB, De Amici E, Mancini M, Pujia A, Fratino P, Giustina A, Garzaniti A. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. Am J Cardiol. 2006;97(2):236–9. https://doi.org/10.1016/j.amjcard.2005.07.133.

Article  CAS  PubMed  Google Scholar 

Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, Rizka A, Tarigan TJE, Harbuwono DS, Purnamasari D, Soewondo P. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr. 2022;16(8):102581. https://doi.org/10.1016/j.dsx.2022.102581.

Article  CAS  PubMed  Google Scholar 

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology. Eur Heart J. 2017;39(2):119–77. https://doi.org/10.1093/eurheartj/ehx393.

Article  Google Scholar 

Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology. Eur Heart J. 2016;37(3):267–315. https://doi.org/10.1093/eurheartj/ehv320.

Article  CAS  PubMed  Google Scholar 

Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. https://doi.org/10.1089/met.2008.0034.

Article  CAS  PubMed  Google Scholar 

Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3): e0149731. https://doi.org/10.1371/journal.pone.0149731.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, Sánchez-Lázaro D, Meza-Oviedo D, Vargas-Vázquez A, Campos OA, Sevilla-González MDR, Martagón AJ, Hernández LM, Mehta R, Caballeros-Barragán CR, Aguilar-Salinas CA. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–44. https://doi.org/10.1530/EJE-17-0883.

Article  CAS  PubMed  Google Scholar 

Cosentino N, Bonomi A, Campodonico J, Veglia F, De Ferrari GM, Genovese S, Marenzi G. Can the in-hospital mortality gap between STEMI patients with and without diabetes mellitus be reduced? The cardio-renal hypothesis. Nutr Metab Cardiovasc Dis. 2021;31(5):1516–20. https://doi.org/10.1016/j.numecd.2021.02.003.

Article  PubMed  Google Scholar 

Karayiannides S, Norhammar A, Frøbert O, James SK, Lagerqvist B, Lundman P. Prognosis in patients with diabetes mellitus and STEMI undergoing primary PCI. J Am Coll Cardiol. 2018;72(12):1427–8. https://doi.org/10.1016/j.jacc.2018.06.061.

Article  PubMed  Google Scholar 

Baviera M, Genovese S, Colacioppo P, Cosentino N, Foresta A, Tettamanti M, Fortino I, Roncaglioni MC, Marenzi G. Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction. Cardiovasc Diabetol. 2022;21(1):223. https://doi.org/10.1186/s12933-022-01655-w.PMID:36309742;PMCID:PMC9618227.

Article  PubMed  PubMed Central  Google Scholar 

Foraker RE, Guha A, Chang H, O’Brien EC, Bower JK, Crouser ED, Rosamond WD, Raman SV. Survival after MI in a community cohort study: contribution of comorbidities in NSTEMI. Glob Heart. 2018;13(1):13–8. https://doi.org/10.1016/j.gheart.2018.01.002.

Article  PubMed  Google Scholar 

Mirr M, Skrypnik D, Bogdański P, Owecki M. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest. 2021;44(12):2831–43. https://doi.org/10.1007/s40618-021-01608-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng W, Kong F, Chen S. Comparison of the predictive value of four insulin resistance surrogates for the prevalence of hypertension: a population-based study. Diabetol Metab Syndr. 2022;14(1):137. https://doi.org/10.1186/s13098-022-00907-9.PMID:36163185;PMCID:PMC9511744.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han R, Zhang Y, Jiang X. Relationship between four non-insulin-based indexes of insulin resistance and serum uric acid in patients with type 2 diabetes: a cross-sectional study. Diabetes Metab Syndr Obes. 2022;9(15):1461–71. https://doi.org/10.2147/DMSO.S362248.

Article  Google Scholar 

Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stifening and cardiovascular disease. Metabolism. 2021;119: 154766.

Article  CAS  PubMed  Google Scholar 

Guo J, Ji Z, Carvalho A, Qian L, Ji J, Jiang Y, Liu G, Ma G, Yao Y. The triglycerides-glucose index and the triglycerides to high-density lipoprotein cholesterol ratio are both effective predictors of in-hospital death in non-diabetic patients with AMI. PeerJ. 2022;21(10): e14346. https://doi.org/10.7717/peerj.14346.

Article  CAS  Google Scholar 

Liao Y, Zhang R, Shi S, Zhao Y, He Y, Liao L, Lin X, Guo Q, Wang Y, Chen L, Li W, Li S, Chen K, Fang Y. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022;21(1):128. https://doi.org/10.1186/s12933-022-01563-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miao M, Bi Y, Hao L, Bao A, Sun Y, Du H, Song L, You S, Zhong C. Triglyceride-glucose index and short-term functional outcome and in-hospital mortality in patients with ischemic stroke. Nutr Metab Cardiovasc Dis. 2023;33(2):399–407. https://doi.org/10.1016/j.numecd.2022.11.004.

Article  CAS  PubMed  Google Scholar 

Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18(1):150. https://doi.org/10.1186/s12933-019-0957-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Liu F, Li W, Zhang J, Zhang T, Yu X, Luo J, Zhao Q, Zhang J, Fang B, Yang Y, Li X. Metabolic score for insulin resistance (METS-IR) predicts adverse cardiovascular events in patients with type 2 diabetes and ischemic cardiomyopathy. Diabetes Metab Syndr Obes. 2023;5(16):1283–95. https://doi.org/10.2147/DMSO.S404878.PMID:37179787;PMCID:PMC10167964.

Article  Google Scholar 

Drwiła-Stec D, Rostoff P, Gajos G, Nessler J, Konduracka E. Predictive value of metabolic score for insulin resistance and triglyceride glucose-BMI among patients with acute myocardial infarction in 1-year follow-up. Coron Artery Dis. 2023. https://doi.org/10.1097/MCA.0000000000001242.

Article  PubMed  PubMed Central  Google Scholar 

Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75. https://doi.org/10.1186/s12933-023-01794-8.PMID:36997935;PMCID:PMC10064664.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopaschuk GD, Verma S. Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review. JACC Basic Transl Sci. 2020;5(6):632–44. https://doi.org/10.1016/j.jacbts.2020.02.004.PMID:32613148;PMCID:PMC7315190.

Article  PubMed  PubMed Central  Google Scholar 

Andrikou E, Tsioufis C, Andrikou I, Leontsinis I, Tousoulis D, Papanas N. GLP-1 receptor agonists and cardiovascular outcome trials: an update. Hellenic J Cardiol. 2019;60(6):347–51.